Multi event Drug Recall Enforcement Report Class II voluntary initiated by Mylan Institutional, Inc., originally initiated on 11-19-2024 for the product Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-443-20 The product was recalled due to subpotent and superpotent drug. The product was distributed nationwide and the recall is currently ongoing.
Recall Enforcement Reports
Recall Number |
Recall Initiation Date |
Report Date |
Recall Classification |
Quantity |
Product Description |
Recall Reason |
Status |
D-0133-2025 | 11-19-2024 | 12-18-2024 | Class II | 1,664 cartons | Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-443-20 | Subpotent and Superpotent Drug | Ongoing |
D-0135-2025 | 11-19-2024 | 12-18-2024 | Class II | 690 cartons | Levothyroxine Sodium Tablets, USP, 150 mcg (0.150 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-445-20 | Subpotent and Superpotent Drug | Ongoing |
D-0132-2025 | 11-19-2024 | 12-18-2024 | Class II | 988 cartons | Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-039-20 | Subpotent and Superpotent Drug | Ongoing |
D-0134-2025 | 11-19-2024 | 12-18-2024 | Class II | 1,133 cartons | Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-041-20 | Subpotent and Superpotent Drug | Ongoing |
D-0136-2025 | 11-19-2024 | 12-18-2024 | Class II | 205 cartons | Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-040-20 | Subpotent and Superpotent Drug | Ongoing |
D-0131-2025 | 11-19-2024 | 12-18-2024 | Class II | 2,835 cartons | Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-442-20 | Subpotent and Superpotent Drug | Ongoing |
Recalled Products